Suchergebnisse - "Aujoulat, Olivier"

PubPharm (7)

1

Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine : Case Report and Literature Review

enthalten in: Laboratory medicine | 2022

von Hammami, E. | Lamarque, M. | Aujoulat, O. | +3

2

Evolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2-targeted treatments : Results from the french personalized reimbursement model database (2011-2018)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Cottu, P. | Coudert, B. | Perol, D. | +7

3

Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2016

von Ojeda-Uribe, M. | Merieau, S. | Guillon, M. | +7

4

Successful rapid desensitization to the antibody-drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2016

von Fizesan, M. | Boin, C. | Aujoulat, O. | +5

5

[278] EFFICIENT ALGORITHMS FOR AN OPTIMIZATION PROBLEM IN A HOSPITAL’S PHARMACY

enthalten in: 45th International Conference on Computers & Industrial Engineering 2015 (CIE45) ; Volume 1 | 2016

von Beroule, B. | Grunder, O. | Barakat, O. | +1

6

Successful rapid desensitization to the antibody-drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma

enthalten in: Journal of oncology pharmacy practice | 2016

von Newinger, G. | Watier, H. | Lustig, H. | +5

7

Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate

enthalten in: Journal of oncology pharmacy practice | 2016

von Ojeda-Uribe, M. | Merieau, S. | Guillon, M. | +7

1
[1]